All data are based on the daily closing price as of April 6, 2026
h

HLB

028300.KQ
34.03 USD
0.18
+0.53%

Overview

Last close
34.03 usd
Market cap
4.46B usd
52 week high
64.07 usd
52 week low
26.03 usd
Target price
110.35 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
80.1161
Price/Book Value
16.0214
Enterprise Value
4.60B usd
EV/Revenue
81.991
EV/EBITDA
-60.8563

Key financials

Revenue TTM
56.06M usd
Gross Profit TTM
18.34M usd
EBITDA TTM
-62.57M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
502.23M usd
Net debt
80.77M usd

About

HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. Additionally, it develops biological drugs with MoA to infectious diseases. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
  • Symbol
    028300.KQ
  • Exchange
    KQ
  • Isin
    KR7028300002
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Mr. Jung-Min Park
  • Headquarter
    Ulsan
  • Web site
    https://www.hlbbio.co.kr/
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top